Article Sidebar
Views PDF: 285
THE RESULTS OF DEFINITIVE TREATMENT FOR HEAD AND NECK CANCER WITH RADIOTHERAPY IN ELDERLY PATIENT AT DA NANG ONCOLOGY HOSPITAL
Main Article Content
Abstract
Objectives: To evaluate the response, toxicity and complication of definitive treatment regimens combine with radiotherapy in the elderly patients with head and neck squamous cell carcinoma (HNSCC). Methods: 37 patients with head and neck cancer ≥ 60 years old who received definitive treatment with radiotherapy, including: postoperative adjuvant radiotherapy, definitive concurrent chemoradiotherapy or definitive radiotherapy alone at Da Nang Oncology Hospital from 1 June 2019 to 31 December 2020 with case series study. Results: The majority of age group belong to 60-70 (70%). Male/ female ratio is 3:1. All patients had good performance status index. The histopathology of the patients was squamous cell carcinoma grade 1 (46%) and squamous cell carcinoma grade 2 (43.2%). Mostly patients cancer stage is stage III and IV (65,1%). Dermatitis, mucositis accounted for 91.9%, pain, dysphagia over 90%, hematologic toxicity 8.1-43.2%, no grade 3/4 toxicities. The complete response rate at 3 months is 89%. The rate of recurrence and metastasis at 6 months was 10.8% (4 cases). Complications of leukopenia, dysphagia, pain reduce the rate of treatment response. Conclusions: Elderly patients with head and neck cancer had good performance status, tolerating effective treatment with appropriate regimens with high response rates and side effects within acceptable limits.
Article Details
Keywords
head and neck cancer, elderly patient, definitive treatment
References
2. Daniel R. Dickstein, Marc Egerman, Erica Monrose, et al. Treatment tolerability and outcomes in elderly patients with head and neck cancer. Head & Neck. 2021;43:858–873
3. Grenman R, Chevalier D, Gregoire V, et al. Treatment of head and neck cancer in the elderly: European consensus (p6) at the EUFOS congress in Vienna 2007. Eur Arch Otorhinolaryngol. 2010;267(10):1619–21.
4. Đặng Huy Quốc Thịnh, Nguyễn Chấn Hùng, Lâm Đức Hoàng và cs. Hóa-xạ trị đồng thời carcinôm vòm hầu giai đoạn tiến xa tại chỗ - tại vùng bằng cisplatin liều thấp mỗi tuần: đánh giá độc tính, đáp ứng, sống còn. Tạp chí Ung thư học Việt Nam, Số 4/2012, 88-103.
5. Pignon JP, le Maitre A, Maillard E, et al. Metaanalysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4–14.
6. Yu JB, Soulos PR, Sharma R, et al. Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012;83:e101–7.
7. Derks W, de Leeuw JR, Hordijk GJ, et al. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol. 2005;262(1):21–6.
8. Haehl E., Rühle A., David H., et al. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly? Radiation Oncology, 15, 31 (2020).